FDAnews
www.fdanews.com/articles/72838-inverness-acquires-rapid-diagnostics-from-abbott

Inverness Acquires Rapid Diagnostics From Abbott

May 31, 2005

Inverness Medical Innovations announced that Inverness will acquire the Determine/DainaScreen assets of Abbott's rapid diagnostics business, which provide rapid qualitative results for detecting several diseases, including hepatitis, HIV and syphilis. Under the terms of the agreement, which is anticipated to close by June 30, Inverness will acquire assets related to the Determine/DainaScreen rapid diagnostics for $56.5 million.

()a href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-31-2005/0003766605&EDATE=" target="_blank">PR Newswire